Antwerpen, Antwerp, Belgium Ackermans & van Haaren is the famous Corporate Investor, which was founded in 1876. The leading representative office of defined Corporate Investor is situated in the Antwerpen. The fund was located in Europe if to be more exact in Belgium.
The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Ackermans & van Haaren, startups are often financed by VIB, Rebright Partners, Qbic. The meaningful sponsors for the fund in investment in the same round are VIB, Toppan Printing, Sunil Kalra.
The high activity for fund was in 2019. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, AgTech. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Among the various public portfolio startups of the fund, we may underline AgroSavfe, OncoDNA The fund has specific favorite in a number of founders of portfolio startups.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vico Therapeutics | $63M | 05 Jan 2024 | Leiden, South Holland, Netherlands | ||
AstriVax | $35M | 25 Aug 2022 | Heverlee, Vlaams-Brabant, Belgium | ||
Medikabazaar | $55M | 22 Sep 2021 | Mumbai, Maharashtra, India | ||
Indigo Diabetes | $44M | 27 Jul 2020 | East Flanders | ||
Medikabazaar | $3M | 18 Jun 2020 | India, Maharashtra | ||
MRM Health NV | $16M | 19 Feb 2020 | East Flanders | ||
OncoDNA | $22M | 14 Feb 2020 | Charleroi, Hainaut, Belgium | ||
Medikabazaar | $14M | 18 Nov 2019 | Mumbai, Maharashtra, India | ||
Biotalys | $41M | 30 Jul 2019 | Ghent, East Flanders, Belgium |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vico Therapeutics | $63M | 05 Jan 2024 | Leiden, South Holland, Netherlands | ||
AstriVax | $35M | 25 Aug 2022 | Heverlee, Vlaams-Brabant, Belgium | ||
Medikabazaar | $55M | 22 Sep 2021 | Mumbai, Maharashtra, India | ||
Indigo Diabetes | $44M | 27 Jul 2020 | East Flanders | ||
Medikabazaar | $3M | 18 Jun 2020 | India, Maharashtra | ||
MRM Health NV | $16M | 19 Feb 2020 | East Flanders | ||
OncoDNA | $22M | 14 Feb 2020 | Charleroi, Hainaut, Belgium | ||
Medikabazaar | $14M | 18 Nov 2019 | Mumbai, Maharashtra, India | ||
Biotalys | $41M | 30 Jul 2019 | Ghent, East Flanders, Belgium |
